Stock screener

KNSA

Conviction 80HealthcareScan · Mon, Aug 10, 2026
Shooting star
KNSA$76.53+0.62%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 818.52K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Kiniksa Pharmaceuticals International, plcPHARMACEUTICAL PREPARATIONSwww.kiniksa.com
Price76.53
Change+0.62%
Gap+0.07%
Rel volume0.77×
Avg volume729.2K
Avg $ vol52.8M
SMA 2069.81
SMA 5061.60
SMA 20049.10
Price vs 50+24.23%
Price vs 200+55.87%
MA stackbullish
50/200 cross
Supertrendup · 68.01
RSI (14)64
MACD hist0.26
MACD crossbull · 9d
Stoch %K / %D70 / 69
ADX (14)43
+DI / −DI34 / 13
RSI divergence
MACD divergence
ATR %+4.38%
ADR %4.54%
52w high80.92
52w low32.15
From 52w high-5.43%
Above 52w low+138.04%
New 52w highNo
SqueezeOff
Bollinger width41.96%
%B0.73
Donchian pos71.98%
Donchian high82.94
Donchian low60.07
AVWAP (52w high)77.13
vs AVWAP high-0.78%
AVWAP (52w low)48.53
vs AVWAP low+57.70%
OBV trendUp
Chaikin MF (20)0.13
Today vs 20d0.77×
Avg vol (14d)818.52K
Avg vol (20d)729.2K
Avg $ vol (20d)52.8M
Market cap6.04B
RS 3m (vs SPY)+27.91%
RS 6m (vs SPY)+64.51%
RS line new highNo
Trend template8/8
Technical rank90.0
1 week+4.25%
1 month+20.63%
3 months+30.60%
6 months+77.61%
1 year+131.14%
YTD+82.19%
P/E102.44
P/B9.98
P/S8.92
P/FCF44.31
EPS0.7500
Div yield
ROE9.74%
ROA7.15%
Debt/Eq
Current3.79
EV/EBITDA74.32
Gross margin
Net margin8.71%
Rev growth60.09%
EPS growth236.61%
Price target96.57
Target upside26.19%
Analyst ratingBuy
Institutional108.08%
Ent. value5.85B
Revenue214.27M
Net income22.59M
Gross profit
Free cash flow136.42M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out46.3M
Employees366
ListedThu, May 24, 2018
Free float38.9M
Float %84.2%
Short interest4.51M
Days to cover6.8d
Short volume62.6%
Squeeze score63 / 100
Next earnings
EPS forecast
Last EPS vs est$0.30 vs $0.30
Last surprise0.0% beat
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank90.0 / 100
Group rank86 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmShooting star
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KNSA

All disclosures →
No recent disclosed trades by Congress in KNSA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KNSA · 6 buys · 2 sells

InsiderSideShares
Patel Sanj K
CHAIRMAN & CEO · Class A Ordinary Share · 2026-06-01
Convert900K
Patel Sanj K
CHAIRMAN & CEO · Class A Ordinary Share · 2026-06-01
Other
Patel Sanj K
CHAIRMAN & CEO · Class B Ordinary Shares · 2026-06-01
Convert900K
McCain Tracey L
Director · Share Option · 2026-05-29
Grant12.16K
Levy Richard S
Director · Restricted Share Units · 2026-05-29
Exercise2.8K
Baker Bros. Advisors (GP) LLC
Director · Class A Ordinary Shares · 2026-05-29
Other
Cole G Bradley
Director · Restricted Share Units · 2026-05-29
Grant2.03K
Popovits Kimberly J
Director · Share Option · 2026-05-29
Grant12.16K
BAKER FELIX
Director · Non- Qualified Share Option (right to buy) · 2026-05-29
Grant36.47K
Popovits Kimberly J
Director · Class A Ordinary Share · 2026-05-29
Exercise2.8K

SEC filings

EDGAR filings in KNSA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.